Modulation of the excitability of avian peripheral nerves by vitamin D: relation to calbindin-D28k, calcium status and lipid composition.
Calbindin-D28k (CaBP), previously localized in some of the cell bodies of ganglia of the avian intestinal (Remark's) nerve, was shown to be vitamin D-dependent. In the present studies, the effect of vitamin D3 on electrophysiological properties of this nerve was examined in vitro. Electrical stimulation of the nerve yielded a compound action potential with two primary components, Peaks I and II. Peak II, suppressed by hexamethonium bromide or Ca(2+)-free buffer, is synaptically mediated. The transit time between the two peaks was unaffected by vitamin D3. The apparent conduction velocity, defined as [(activation time + transit time)/nerve length], was increased by vitamin D-deficiency and decreased by vitamin D3 repletion, the latter decrease due entirely to an increase in activation time. Activation time after vitamin D-repletion was correlated with an increase in CaBP and plasma Ca2+ levels. However, normalization of plasma Ca2+ by supplementation of vitamin D-deficient diets with excess calcium (2.5 and 4.0%) also resulted in an increase in activation time, without affecting neuronal CaBP levels. Vitamin D3 also decreased the conduction velocity and increased CaBP of the vagus nerve and, by lipid analysis, was shown to increase and decrease its phosphatidylcholine and phosphatidylethanolamine content, respectively, and to decrease its phospholipid/cholesterol ratio. Modulation of peripheral nerve activity by vitamin D3 is related to calcium status and perhaps to changes in lipid composition. The functional role of CaBP in the behaviour of this complex nerve remains unknown.
Cai
Q
Q
Department of Physiology, College of Veterinary Medicine, Cornell University, Ithaca, New York.
Tapper
D N
DN
Gilmour
R F
RF
deTalamoni
N
N
Aloia
R C
RC
Wasserman
R H
RH
D000818:Animals; D064026:Calbindins; D002118:Calcium / Q000097:blood*; D002136:Calcium, Dietary / Q000494:pharmacology*; D002645:Chickens; D002784:Cholesterol / Q000378:metabolism; D004594:Electrophysiology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D010525:Peripheral Nerves / Q000737:chemistry / Q000502:physiology*; D010713:Phosphatidylcholines / Q000032:analysis; D010714:Phosphatidylethanolamines / Q000032:analysis; D010743:Phospholipids / Q000032:analysis; D064030:S100 Calcium Binding Protein G / Q000032:analysis* / Q000502:physiology*; D014807:Vitamin D / Q000494:pharmacology / Q000502:physiology*
D064026:Calbindins; D002136:Calcium, Dietary; D006584:Hexamethonium Compounds; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D064030:S100 Calcium Binding Protein G; D014807:Vitamin D; D002784:Cholesterol; D002118:Calcium